Cost-effectiveness analysis of gestational diabetes mellitus screening in France
| Autor: | Sandrine Touzet, Michel Berland, Bénédicte Poncet, Laure Rocher, Jacques Orgiazzi, Cyrille Colin |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
Cost-Benefit Analysis Pregnancy Complications Cardiovascular Fetal Macrosomia Pregnancy Risk Factors Diabetes mellitus Infant Mortality Medicine Humans Mass Screening Prospective Studies Prospective cohort study Glucose tolerance test medicine.diagnostic_test business.industry Perinatal mortality Obstetrics Infant Newborn Obstetrics and Gynecology Cost-effectiveness analysis Glucose Tolerance Test medicine.disease Surgery Gestational diabetes Diabetes Gestational Reproductive Medicine Gestation Female France business |
| Zdroj: | European journal of obstetrics, gynecology, and reproductive biology. 103(2) |
| ISSN: | 0301-2115 |
| Popis: | Objective: To compare three strategies for gestational diabetes screening (i) screening of high-risk pregnant women with the 50 g oral glucose tolerance test (OGTT); (ii) screening of all pregnant women with the 50 g OGTT; (iii) screening of all pregnant women according to the 75 g OGTT. Study design: Cost-effectiveness analysis. The outcome measures, i.e. macrosomia, prematurity, perinatal mortality, hypertensive disorders rates were estimated from published studies and the costs from a prospective study involving 120 pregnant women. Results: Compared to the first strategy, the cost to obtain one unit of additional effectiveness with the second screening strategy, was up to 1.1 times more expensive, and with the third strategy was up to 3.7 times more expensive. Conclusion: The costs per case prevented reflect a favourable cost-effectiveness ratio (CER) for screening of high-risk pregnant women by 50 g oral glucose test. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect